<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>210</id><JournalTitle>ADVANCEMENTS IN TARGETED THERAPIES: HARNESSING SIGNAL TRANSDUCTION PATHWAYS FOR DISEASE TREATMENT</JournalTitle><Abstract>The current progress in the study of signal transduction pathways has transformed the design of targeted therapy to a wide
range of diseases, such as cancer, cardiovascular diseases, neurodegenerative diseases, and metabolic diseases. Signal
transduction pathways are the signaling pathways that mediate important cellular processes like growth, survival,
differentiation, and metabolism. The malfunction of these pathways usually results in pathological states and as such, they are
desirable targets in terms of therapeutic measures. Recent advances in the field of small molecule inhibitors, biologics, and
gene therapies have made it possible to precisely adjust these pathways by providing superior and less toxic treatment
alternatives to the traditional therapies. In this review, the author discusses the importance of the major signaling pathways in
pathogenesis of disease and the potential prospects in targeted therapy of those pathways. We also discuss the limitations of
targeting these pathways particularly off-target effects and drug resistance and possibilities of personalized medicine in the
future when designing therapeutic approaches</Abstract><Email>harshithavanacharla9102@gmail.com</Email><articletype>Research</articletype><volume>16</volume><issue>1</issue><year>2026</year><keyword> Signal Transduction, Targeted Therapies, Cancer Treatment, Personalized Medicine</keyword><AUTHORS>Harshitha V1*, Shaik Suhana Tahrannum1, Diyanka G1, Ramya Sri V,Dr. Akila C.R</AUTHORS><afflication>Pharm. D Intern, Department of Pharmacy Practice, KLR Pharmacy College, Paloncha, Telangana, India,Professor, Department of Pharmacology, KLR Pharmacy College, Paloncha, Telangana, India.</afflication></Article></Articles>